SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $91.18 | 52-week high | $103.52 |
Prev. close | $92.59 | 52-week low | $63.80 |
Day low | $90.85 | Volume | 7,394,200 |
Day high | $93.05 | Avg. volume | 11,457,228 |
50-day MA | $90.24 | Dividend yield | 0.02% |
200-day MA | $83.08 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 7.07B |
Net Asset Value (NAV) | $92.58 |
Options? | Yes |
Total Holdings | 140 |
XBI Top Holdings
Symbol | Company | % of Total |
ALPN | ALPINE IMMUNE SCIENCES INC | 1.79% |
CRNX | CRINETICS PHARMACEUTICALS IN | 1.3% |
RVMD | REVOLUTION MEDICINES INC | 1.28% |
MRNA | MODERNA INC | 1.28% |
BPMC | BLUEPRINT MEDICINES CORP | 1.27% |
AMGN | AMGEN INC | 1.21% |
VKTX | VIKING THERAPEUTICS INC | 1.2% |
TWST | TWIST BIOSCIENCE CORP | 1.19% |
UTHR | UNITED THERAPEUTICS CORP | 1.16% |
XBI Price Returns
1-mo | 9.22% |
3-mo | -2.11% |
6-mo | 24.09% |
1-year | 6.83% |
3-year | -27.01% |
5-year | 13.19% |
YTD | 2.12% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |